Data Source: VIR Presentation 22nd Wainwright 22nd Annual Conference These developments present exciting market opportunities ... and the RSI ranges on the chart below, especially in August ...

Analysts have set 12-month price targets for Vir Biotechnology, revealing an average target of $34.83, a high estimate of ...

Vir Biotechnology Inc. advanced stock charts by Barron's. View VIR historical stock data and compare to other stocks, and exchanges.

See the top stocks recommended by analysts >> VIR market cap is currently $3.09B and has a P/E ratio of -21.02. TipRanks has tracked 36,000 company insiders and found that a few of them are better ...

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious ...